Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Jul 11.
Published in final edited form as: Tetrahedron Lett. 2012 May 3;53(28):3563–3567. doi: 10.1016/j.tetlet.2012.04.136

Sanctolide A, a 14-membered PK-NRP hybrid macrolide from the cultured cyanobacterium Oscillatoria sancta (SAG 74.79)

Hahk-Soo Kang 1, Aleksej Krunic 1, Jimmy Orjala 1,*
PMCID: PMC3375721  NIHMSID: NIHMS379939  PMID: 22711943

Abstract

Sanctolide A (1), a 14-membered polyketide-nonribosomal peptide (PK-NRP) hybrid macrolide, was isolated from the cultured cyanobacterium Oscillatoria sancta (SAG 74.79). The planar structure was determined using various spectroscopic techniques including HRESIMS, and 1D and 2D NMR analyses. The relative configuration was assigned by J-based configurational analysis in combination with NOE correlations. The absolute configuration was determined by Mosher ester and enantioselective HPLC analyses. The structure of sanctolide A (1) features a rare N-methyl enamide and a 2-hydroxyisovaleric acid, which are incorporated to form a 14-membered macrolide ring structure, comprising a new type of cyanobacterial macrolides derived from a PKS-NRPS hybrid biosynthetic pathway.

Keywords: cyanobacteria, Oscillatoria sancta, 14-membered macrolide, PK-NRP hybrid, brine shrimp toxicity


Cyanobacteria (blue-green algae) have been shown to be prolific producers of bioactive secondary metabolites.13 Polyketide-nonribosomal peptide (PK-NRP) hybrids represent a major class of cyanobacterial secondary metabolites.4 Diverse cyanobacterial metabolites belonging to this class have been isolated from both freshwater and marine cyanobacteria. A major group of cyanobacterial PK-NRP hybrid metabolites is lipopeptides, where linear or cyclic peptides contain one lipophilic residue of polyketide origin such as β-amino acid and N-acyl residues.2 Another subclass of cyanobacterial PK-NRP hybrid metabolites is comprised of macrolides whose building blocks are mainly acetates with one or two amino acids incorporated into their macrolide ring structures. These compounds are less commonly found in cyanobacteria. Examples include laingolide, laingolides A and B, madangolide and palmyrolide A, all of which have 15-membered macrolide rings containing a rare N-methyl enamide functionality. 58 These metabolites were all obtained from marine cyanobacteria belonging to the order Oscillatoriales.

In our continuing search for biologically active secondary metabolites from cultured cyanobacteria, the cell extract of Oscillatoria sancta (SAG 74.79) was initially evaluated for its activity in a brine shrimp toxicity assay and found to be active. Herein, we report the isolation and structure determination of a 14-membered PK-NRP hybrid macrolide, named sanctolide A (1). The planar structure was determined using spectroscopic techniques including HRESIMS, and 1D and 2D NMR analyses. The relative configuration of 1 was solved by J-based configurational analysis along with NOE correlations, and Mosher ester and enantioselective HPLC analyses were carried out for the assignment of the absolute configuration.

Oscillatoria sancta was obtained from the SAG (Sammlung von Algenkulturen Göttingen) culture collection of algae (strain ID: 74.79), and grown in inorganic media (BG-12).9 The freeze-dried cells were extracted with a mixture of CH2Cl2-MeOH (1:1 v/v). This organic extract was fractionated using Diaion HP-20 resin with an increasing amount of iPrOH in water. The fractions eluting at 70% and 80% iPrOH displayed toxicity against brine shrimp. HPLC-based activity profiling of these fractions using reversed-phase column identified one minor peak as the active component (Figure S2 in Supplementary data). Dereplication by LC-MS and 1H NMR indicated this peak to be a potentially new metabolite with a molecular weight of 439 Da. Scale-up culture (4 × 2L) and re-isolation was performed using the method described above followed by reversed-phase HPLC to yield sanctolide A (1, 2.6 mg, Figure 1).

Figure 1.

Figure 1

The structure of sanctolide A (1).

Sanctolide A (1)10 was obtained as colorless oil. The molecular formula of 1 was established as C24H41NO6 by HRESIMS analysis. Analysis of the 1H NMR spectrum of 1 in combination with the DEPT-Q and HSQC spectra indicated the presence of two olefinic protons (δH 6.70 and 5.12), three oxygenated methines (δH 5.11, 5.00 and 3.12), one O-methyl (δH 3.28), one N-methyl (δH 3.06), two methines (δH 2.56 and 2.31), five diastereotopic methylenes (δH 2.0 – 1.0), three homotopic methylenes (δH 1.28 and 1.24), as well as three dolublet (δH 1.13, 0.94 and 0.90) and one triplet methyl (δH 0.87) protons. Analysis of the COSY spectrum established three partial structures 1a, 1b and 1c (Figure 2). The first partial structure (1a) was assembled by sequential COSY correlations from H-2 (δH 2.56) to H3-12 (δH 0.87) along with a COSY correlation between H-2 and H3-13 methyl (δH 1.13). Down-field chemical shifts of H-5 (δH 5.00) and H-7 (δH 3.12) indicated that C-5 and C-7 were oxygenated. The second partial structure (1b) was established from COSY correlations between H-15 (δH 5.11) and H-16 (δH 2.31), and between H-16 and H3-17/H3-18 methyl protons (δH 0.94/0.90). A downfield chemical shift of H-15 (δH 5.11) and the absence of a NH signal indicated this partial structure to be a 2-hydroxyisovaleric acid. This was further supported by chemical shifts of C-15 (δC 77.0) and C-19 (δC 168.7).. COSY correlations between H-20 (δH 3.20 and 3.15)/H-21 (δH 5.12)/H-22 (δH 6.70) determined the last partial structure as a 1, 3-functionalized propylene (1c) possessing the trans geometry due to the large 3JHH (14.0 Hz) observed between H-21 and H-22.

Figure 2.

Figure 2

Key 2D NMR correlations used to determine the planar structure of 1.

The three partial structures (1a, 1b and 1c) were assembled through HMBC correlations (Figure 2). An HMBC correlation from the O-methyl singlet (δH 3.28) to C-7 methine (δC 77.7) placed a methoxy group at C-7. The chemical shift of C-14 (δC 170.0) combined with HMBC correlations from H-5 (δH 5.00) and H-16 (δH 2.31) to C-14 allowed the assembly of partial structures 1a and 1b via an ester linkage. The connection between substructures 1b and 1c was established by HMBC correlations from H-15 (δH 5.11) and H-21 (δH 5.12) to C-19 (δC 168.7), positioning the 2-hydroxyisovaleric acid between 1a and 1c via two ester linkages. HMBC correlations from an N-methyl singlet (δH 3.06) to C-22 (δC 132.4) and C-1 (δC 174.5), and from H3-13 (δH 1.13) to C-1 linked 1a and 1c through the N-methyl enamide bridge, completing the assembly of a 14-membered macrolide ring scaffold.

The relative configuration between C5 and C7 was determined by J-based configurational analysis11 in combination with NOE correlations (Figure 3). Homonuclear (3JHH) and heteronuclear (2JCH and 3JCH) coupling constants were obtained from the DQF-COSY and GBIRD-HSQMBC spectra, respectively.12, 13 A small 3JH5H6a (3.8 Hz) and a large 3JH5H6b (8.1 Hz) indicated the gauche conformation between H-5 and H-6a and the anti conformation between H-5 and H-6b, respectively, leaving A3 and A4 as two possible conformations (Figure S3 in Supplementary data). An NOE correlation observed between H2-4 and H-6a indicated A4 to be the only possible conformation, allowing the stereospecific assignments of the diastereotopic protons H-6a/b (Figure 3). For the C6–C7 bond, only two conformations B1 and B5 were possible based on a large 3JH6aH7 (9.0 Hz) and a small 3JH6bH7 (2.9 Hz) (Figure S3 in Supplementary data). An NOE correlation observed between H-6b and H2-8 and between H-5 and OMe left B1 as the only possible conformation, thus allowing the assignment of the anti configuration for the 1,3-methine system at C5–C7. Determination of the relative configuration for the 1,4-methine system between C-2 and C-5 using NMR methods was complicated as analysis of the NOE spectrum indicated the presence of multiple conformations for the macrolide ring in 1. The proton H-5 showed NOE correlations with all of four diastereotopic protons including H-3a/b and H-4a/b, and a NOESY experiment recorded with a short mixing time (200 ms) verified these cross-peaks to be real NOE correlations as opposed to artifacts arising from spin diffusion. A J-based configurational analysis was attempted but unsuccessful due to a number of medium J values observed for this 1,4 methine system. Attempts to crystallize 1 were also unsuccessful due to the labile nature of an enamide moiety and the presence of a 12 carbons-long fatty acid branch. Therefore, the configuration of a stereocenter at C-2 could not be assigned.

Figure 3.

Figure 3

Newman projections for A4: C5–C6 and B1: C6–C7. The DQF-COSY and GBIRD-HSQMBC spectra were used for the measurement of homo- and hetero-nuclear coupling constants. Labels in parentheses denote the predicted size of coupling constants: S-small, M-medium and L-large. No correlation observed in the HSQMBC spectrum was assigned as a coupling of 0 Hz. Observed nOe correlations are presented as arched arrows. A full list of rotamers can be found in Supplementary data.

The absolute configuration at C-5, C-7 and C-15 was established by Mosher ester and enantioselective HPLC analyses (Figure 4). 1H NMR and LC-MS analyses indicated that acid hydrolysis of 1 resulted in the formation of 2 due to the labile nature of an enamide moiety under acidic conditions, similar as reported for palmyrolide A by Pereira et al.7 The isolation of 2 from the acid hydrolysate was necessary for Mosher ester analysis, but challenging due to the lack of a chromophore. Alternatively, solvolysis of 1 was carried out using NaOMe in MeOH, and the resulting product was dried in vacuo for 24 hrs. 1H NMR and LC-MS analyses identified the presence of 2 as a sole product14 probably due to volatile nature of the other methyl ester products. The resulting solvolysis product was subjected to Mosher ester analysis. Two equal portions of 2 were derivatized with (R)- and (S)-MTPA chlorides at C-5 to yield (S)- and (R)-MTPA esters (2S and 2R), respectively.15, 16 Interpretation of the 1H NMR chemical shift differences (ΔδS-R) between 2S and 2R assigned the S configuration to C-5, thereby leading to the assignment of the absolute configuration as 5S,7S. The absolute configuration of the remaining 2-hydroxyisovaleric acid residue (3) was assigned by enantioselective HPLC analysis of the acid hydrolysate.17 Comparison of the retention times between the acid hydrolysate of 1 and two authentic standards L- and D-2-hydroxyisovaleric acids allowed the absolute configuration of 3 to be assigned as L.

Figure 4.

Figure 4

Methanolysis and acid hydrolysis for the absolute configuration of 1 at C-5 and C-15; ΔδS-R values (ΔδS-R = δSδR) for the MTPA esters 2S and 2R.

As observed for other enamide-containing natural products,58 compound 1 was highly labile and underwent rapid enamide hydrolysis in the presence of water or acid, resulting in an opening of the macrolide ring. Pereira et al. proposed the mechanism of enamide hydrolysis in acidic conditions.7 This eneamide hydrolysis can also occur in netural pH in a similar manner and involves the reversible conversion of the eneamide moiety into an iminium ion, which undergoes addition by water followed by proton transfer, leading to the formation of a secondary amide and an aldehyde (Figure 5). A degradation experiment indicated that the enamide of 1 was completely hydrolyzed in 48 hrs at rt upon addition of water at similar concentrations used in our biological assay systems, indicating that the macrolide ring structure would be degraded during biological evaluation (see Supplementary data). Sanctolide A (1) exhibited moderate toxicity to brine shrimp with an LD50 value of 23.5 μM. Compound 1 was also evaluated for its cytotoxicity against the HT-29 and MDA-MB-435 cell lines as well as antibacterial activity against E. coli and S. aureus, but no activity was found in either assay system at the highest concentration tested (25 μg/mL). Based on the degradation observed above, it is suggested that compound 1 was present in the acyclic form during the biological evaluation, and this acyclic form of 1 was moderately toxic to brine shrimp.

Figure 5.

Figure 5

Proposed enamide hydrolysis of 1 in neutral pH that leads to ring-opening of the macrolide ring structure.

Sanctolide A (1) features a new class of cyanobacterial macrolides where two amino acid precursors Gly and Val are incorporated into a polyketide chain to form a 14-membered macrolide ring structure. The biosynthesis of 1 was proposed as follows: The first step of biosynthesis involves the formation of a hexaketide (C1 – C12) chain by six PKS modules with α-branched methyl (C-13), which is likely originated from S-adenosyl-L-methionine (SAM).18 This hexaketide chain is further expanded with N-methyl glycine by a NRPS module followed by ketide extension by one acetate unit, reduction, dehydration and double bond isomerization, resulting in the formation of the C21–C22 enamide functionality as proposed for the palmyrolide A.7 The 2-hydroxyisovaleric acid linked to the hydroxyl group at C-5 is likely formed by transamination of Val followed by reduction.18 The cyclization between C-15 hydroxyl and C-19 carboxyl group is likely to occur in a final step, thus completing the proposed biosynthesis of 1.

Supplementary Material

01

Acknowledgments

This research was supported by PO1 CA125066 from NCI/NIH. We thank Dr. B. Ramirez from Center for Structural Biology at UIC for providing an access to 600 and 900 MHz NMR spectrometers. We also thank Q. Shen and Dr. S. M. Swanson for performing cytotoxicity assays, and Drs. S. Cho and S. Franzblau from the Institute for Tuberculosis Research (ITR) at UIC for conducing anti-fungal and anti-bacterial assays. LC-MS and HRESIMS analyses were performed at UIC Research Resource Center (RRC) Mass Spectrometry Facility.

Footnotes

Supplementary Data: Experimental detail; HPLC-based activity profiling; the full list of rotamers for J-based configurational analysis; 1H NMR, COSY, HSQC, HMBC, DQF-COSY, HSQMBC and NOESY spectra of 1;1H NMR spectra of 2, 2S and 2R; 1H NMR spectra of the degraded products.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References and notes

  • 1.Tan LT. Phytochemistry. 2007;68:954–979. doi: 10.1016/j.phytochem.2007.01.012. [DOI] [PubMed] [Google Scholar]
  • 2.Wagoner RMV, Drummond AK, Wright JLC. Adv Appl Microbiol. 2007:89–217. doi: 10.1016/S0065-2164(06)61004-6. [DOI] [PubMed] [Google Scholar]
  • 3.Chlipala GE, Mo S, Orjala J. Curr Drug Targets. 2011;12:1654–1673. doi: 10.2174/138945011798109455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Singh S, Kate BN, Banerjee UC. Critical Rev Biotech. 2005;25:73–95. doi: 10.1080/07388550500248498. [DOI] [PubMed] [Google Scholar]
  • 5.Klein D, Braekman JC, Daloze D. Tetrahedron Lett. 1996;37:7519–7520. [Google Scholar]
  • 6.Klein D, Braekman JC, Daloze D, Hoffmann L, Castillo G, Demoulin V. J Nat Prod. 1999;62:934–936. doi: 10.1021/np9900324. [DOI] [PubMed] [Google Scholar]
  • 7.Pereira AR, Cao Z, Engene N, Soria-Mercado IE, Murray TF, Gerwick WH. Org Lett. 2010;12:4490–4493. doi: 10.1021/ol101752n. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Matthew S, Salvador LA, Schupp PJ, Paul VJ, Luesch H. J Nat Prod. 2010;73:1544–1552. doi: 10.1021/np1004032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Falch BS, Konig GM, Wright AD, Sticher O, Angerhofer CK, Pezzuto JM, Bachmann H. Planta Med. 1995;61:321–328. doi: 10.1055/s-2006-958092. [DOI] [PubMed] [Google Scholar]
  • 10.Sanctolide A (1): colorless oil; [α]25D-41 (c 0.1, MeOH); UV (MeOH) λmax (log ε) 234 (3.77) nm; IR (neat) νmax 2964, 2928, 1736, 1678, 1638 cm−1;1D and 2D NMR data, see Table 1; HRESIMS m/z 440.3005 [M+H]+ (calcd for C24H42NO6, 440.3012)
  • 11.Matsumori N, Kaneno D, Murata M, Nakamura H, Tachibana K. J Org Chem. 1999;64:866–876. doi: 10.1021/jo981810k. [DOI] [PubMed] [Google Scholar]
  • 12.Rance M, Sørensen OW, Bodenhausen G, Wagner G, Ernst RR, Wüthrich K. Biochem Biophys Res Commun. 1983;117:479–485. doi: 10.1016/0006-291x(83)91225-1. [DOI] [PubMed] [Google Scholar]
  • 13.Williamson RT, Márquez BL, Gerwick WH, Kövér KE. Magn Reson Chem. 2000;38:265–273. [Google Scholar]
  • 14.Methanolysis of 1: A portion of 1 (1.2 mg) was treated with 1 mL of 0.5 N NaOMe in MeOH and stirred for 24 h at 25°C. The resulting mixture was extracted with CH2Cl2 two times and dried in vacuo overnight to give 0.8 mg of 2 as a sole product. Compound 2: colorless oil; 1H NMR data (600 MHz, CDCl3) δ 5.58 (1H, m, NH), 3.87 (1H, m, H-5), 3.44 (1H, m, H-7), 3.34 (3H, s, OCH3), 2.78 (3H, d, J = 4.6 Hz, NCH3), 2.23 (1H, m, H-2), 1.73 (1H, m, H-3b), 1.67 (1H, ddd, J = 14.6, 8.9 and 2.9 Hz, H-6b), 1.60 (1H, m, H-8a), 1.52 (1H, ddd, J = 14.6, 6.4 and 1.4 Hz, H-6a), 1.44 (1H, m, H-3a), 1.43 (2H, m, H2-4), 1.42 (1H, m, H-8a), 1.28 (2H, m, H2-11), 1.27 (2H, m, H2-9), 1.27 (2H, m, H2-10), 1.13 (3H, d, J = 6.9 Hz, H3-13), 0.87 (3H, t, J = 7.0 Hz, H3-12); HRESIMS m/z 274.2386 [M+H]+ (calcd for C15H32NO3, 274.2382)
  • 15.(S)-MTPA ester of 2 (2S): Compound 2 (0.4 mg) was dissolved in 200 μL of dry CH2Cl2. Then, 5 μL of (R)-MTPA chloride and catalytic amount of DMAP were added into the solution. After standing overnight at room temperature, the reaction mixture was concentrated in vacuo and redissolved in MeOH. The product was purified by reversed phase ODS HPLC using a gradient from 75 to 95 % aqueous MeOH for 40 min to yield 0.3 mg of 2S. (S)-MTPA ester (2S): colorless oil; 1H NMR data (600 MHz, CDCl3) δ 7.48 – 7.56 (2H, m, Ar-H), 7.39 – 7.41 (3H, m, Ar-H), 5.31 (1H, m, NH), 5.30 (1H, m, H-5), 3.60 (3H, s, OCH3), 3.26 (3H, s, OCH3), 3.06 (1H, m, H-7), 2.74 (3H, d, J = 4.9 Hz, NCH3), 2.07 (1H, m, H-2), 1.73 (1H, ddd, J = 14.7, 9.3 and 2.8 Hz, H-6b), 1.58 (1H, m, H-6a), 1.53 (2H, m, H2-4), 1.52 (1H, m, H-3b), 1.49 (1H, m, H-8b), 1.35 (1H, m, H-8a), 1.28 (2H, m, H2-11), 1.24(1H, m, H-3a), 1.24 (2H, m, H2-9), 1.24 (2H, m, H2-10), 1.03 (3H, d, J = 6.9 Hz, H3-13), 0.86 (3H, t, J = 7.3 Hz, H3-12); HRESIMS m/z 512.2592 [M+Na]+ (calcd for C25H38NO5Na, 512.2600)
  • 16.(R)-MTPA ester of 2 (2R): Compound 2R was prepared from 2 and (S)-MTPA chloride in the same manner as described for 2S. (R)-MTPA ester (2R): colorless oil; 1H NMR data (600 MHz, CDCl3) δ 7.48 – 7.56 (2H, m, Ar-H), 7.39 – 7.41 (3H, m, Ar-H), 5.39 (1H, m, NH), 5.29 (1H, m, H-5), 3.60 (3H, s, OCH3), 3.23 (3H, s, OCH3), 2.93 (1H, m, H-7), 2.77 (3H, d, J = 4.9 Hz, NCH3), 2.13 (1H, m, H-2), 1.66 (1H, ddd, J = 14.6, 9.5 and 2.5 Hz, H-6b), 1.64 (1H, m, H-3b), 1.63 (2H, m, H2-4), 1.53 (1H, m, H-6a), 1.43 (1H, m, H-8b), 1.37 (1H, m, H-3a), 1.27 (1H, m, H-8a), 1.24 (2H, m, H2-11), 1.17 (2H, m, H2-9), 1.17 (2H, m, H2-10), 1.08 (3H, d, J = 6.9 Hz, H3-13), 0.85 (3H, t, J = 7.2 Hz, H3-12); HRESIMS m/z 512.2595 [M+Na]+ (calcd for C25H38NO5Na, 512.2600)
  • 17.Absolute configuration of the 2-hydroxyisovaleric acid residue (3): A portion of 1 (200 μg) was hydrolyzed in 6 N HCl (1 mL) at 110°C for 16 h. The acid hydrolysate of 1 was evaporated to dryness and then re-dissolved in 200 μL of water. HPLC analysis was carried out on a chiral column by comparing the retention times of the components of the hydrolysate with those of authentic standards. Condition: 15% CH3CN in 2 mM CuSO4, 1 ml/min, Phenomenex Chirex phase 3126 (4.6 × 250 mm) column; elution times (tR, min) for standards: L-2-hydroxyisovaleric acid (34.2 min), D-2-hydroxyisovaleric acid (53.3 min). The acid hydrolysate of 1 exhibited a peak at 34.3 min, corresponding to L-2-hydroxyisovaleric acid.
  • 18.Jones AD, Monroe EA, Eisman EB, Gerwick L, Sherman DH, Gerwick WH. Nat Prod Rep. 2010;27:10481–065. doi: 10.1039/c000535e. [DOI] [PubMed] [Google Scholar]

Table 1.

NMR spectroscopic data for sanctolide A (1) in CDCl3

sanctolide A (1)
δCa,c δHb,c mult.(J in Hz) COSYb HMBCb NOESYb,d
1 174.5
2 38.1 2.56 m 3, 13 1, 3, 4, 13 3b, 4a, 13, 22
3 a 29.2 1.21 m 2, 4 1, 2, 4, 5, 13 3b, 4b, 13
b 1.68 m 2, 3a, 4a, 5
4 a 34.1 1.42 m 3, 5 2, 3 3b, 4b, 13
b 1.86 m 3a, 4a, 5, 13
5 73.3 5.00 m 4, 6 3, 4, 6, 7, 14 3a, 3b, 4a, 4b, 6a, 6b, 7, OMe
6 a 40.3 1.59 ddd (14.4, 9.0, 4.2) 5, 7 4, 5, 7, 8 4a, 4b, 6b, 7, OMe
b 1.74 ddd (14.4, 7.8, 3.0) 6a, 5, 7, 8a, 8b
7 77.7 3.12 m 6, 8 5, 6, O-Me 5, 6a, 6b, 7, 8a, 8b
8 a 33.2 1.37 m 7, 9 6, 7, 9, 10 6a, 6b, 8b
b 1.50 m 6b, 7, 8a, OMe
9 32.0 1.24 m 8, 10 7, 8, 10, 11
10 24.3 1.24 m 9, 11 8, 9, 11, 12
11 22.6 1.28 m 10, 12 9, 10, 12
12 14.2 0.87 t (7.1) 11 10, 11
13 14.9 1.13 d (6.9) 2 1, 2, 3 2, 3a, 4a, 4b
14 170.0
15 77.0 5.11 d (6.4) 16 14, 16, 17, 18, 19 16, 17, 18
16 29.6 2.31 sd (6.8, 6.4) 15, 17, 18 14, 15, 17, 18 15, 17, 18
17 18.6 0.94 d (6.8) 16, 18 15, 16, 18
18 17.2 0.90 d (6.8) 16, 17 15, 16, 17
19 168.7
20 34.5 3.15 dd (6.5, 1.3) 21 19, 21, 22 21, 22
3.20 d (6.9)
21 102.7 5.12 m 20 19, 20, 22 20, 22, NMe
22 132.4 6.70 d (14.0) 21 1, 20, N-Me 2, 3b, 20, 21, NMe
O-Me 56.6 3.28 s 7 5, 6a, 8a, 8b, 17
N-Me 30.6 3.06 s 1, 22 21, 22
a

assigned using the DEPT-Q spectrum recorded at 226 MHz,

b

recorded at 600 MHz,

c

chemical shifts were referenced to the CDCl3 solvent signals (δH 7.24 and δC 77.2)

d

mixing time: 600 ms

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

01

RESOURCES